Caricamento...
Simvastatin-romidepsin combination kills bladder cancer cells synergistically
The HMG-CoA reductase inhibitor simvastatin activates AMP-activated protein kinase (AMPK) and thereby induces histone acetylation. We postulated that combining simvastatin with the histone deacetylase (HDAC) inhibitor romidepsin would kill bladder cancer cells by inducing histone acetylation coopera...
Salvato in:
| Pubblicato in: | Transl Oncol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Neoplasia Press
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8220249/ https://ncbi.nlm.nih.gov/pubmed/34144348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2021.101154 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|